Biotransformation research advances - 2022 year in review.

IF 3.4 2区医学 Q2 PHARMACOLOGY & PHARMACY

Drug Metabolism Reviews Pub Date : 2023-11-01 Epub Date: 2023-10-28 DOI:10.1080/03602532.2023.2262161

S Cyrus Khojasteh, Upendra A Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D Crouch, Deepika Dhaware, Carley J S Heck, Kevin M Johnson, Amit S Kalgutkar, Lloyd King, Joyce Liu, Bin Ma, Hlaing Maw, Grover P Miller, Herana Kamal Seneviratne, Ryan H Takahashi, Shuai Wang, Cong Wei, Klarissa D Jackson

引用次数: 0

Abstract

This annual review is the eighth of its kind since 2016 (Baillie et al. 2016, Khojasteh et al. 2017, Khojasteh et al. 2018, Khojasteh et al. 2019, Khojasteh et al. 2020, Khojasteh et al. 2021, Khojasteh et al. 2022). Our objective is to explore and share articles which we deem influential and significant in the field of biotransformation.

查看原文本刊更多论文

生物转化研究进展-2022年回顾。

这是自2016年以来的第八次年度审查（Baillie等人，2016，Khojasteh等人，2017，Khojarteh等人，2018，Khojasiteh等人，2019，Khojalteh等人，2020，Khojanteh等人，2021，Khojaiteh等人，2022）。我们的目标是探索和分享我们认为在生物转化领域有影响力和重要意义的文章。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug Metabolism Reviews 医学-药学

CiteScore

11.10

自引率

1.70%

发文量

审稿时长

1 months

期刊介绍： Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.